Silent myocardial ischemia is more frequent among type 2 diabetic patients than in non diabetic matched controls. In addition silent myocardial ischemia has a higher predictive value for cardiovascular events than the classical cardiovascular risk factors. There is increasing evidence that intensive medical therapy indicated in diabetic patients at high risk of cardiovascular disorders is as effective as invasive revascularization. Consistently silent myocardial ischemia in patients with type 2 diabetes may reverse over time. There is 80% risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes at high cardiovascular risk. So it is advisable to detect coronary artery disease at the silent stage to prevent cardiac events. However screening all patients with type 2 diabetes for silent ischemia would collapse the health care system. Recent studies try to establish clinical markers for the prediction of silent myocardial ischemia in patients with type 2 diabetes. Manouchehr Nakhjavani, Diabetic Foot Ulcer is a Significant Predictor of Silent Myocardial Ischemia in Women with Type 2 Diabetes
Last date updated on September, 2024
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi